Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort

Marco H Ji,1 Natalia F Callaway,1 Margaret A Greven,2 Daniel Vail,1 Darius M Moshfeghi1 1Byers Eye Institute, Horngren Family Vitreoretinal Center, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California; 2Department of Ophthalmology, Wake Forest University School...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ji MH, Callaway NF, Greven MA, Vail D, Moshfeghi DM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/c80a5fc3eb0e413aa81e8dab410cd517
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c80a5fc3eb0e413aa81e8dab410cd517
record_format dspace
spelling oai:doaj.org-article:c80a5fc3eb0e413aa81e8dab410cd5172021-12-02T10:02:41ZTelemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort1177-5483https://doaj.org/article/c80a5fc3eb0e413aa81e8dab410cd5172020-04-01T00:00:00Zhttps://www.dovepress.com/telemedicine-follow-up-for-intravitreal-bevacizumab-injection-in-the-s-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Marco H Ji,1 Natalia F Callaway,1 Margaret A Greven,2 Daniel Vail,1 Darius M Moshfeghi1 1Byers Eye Institute, Horngren Family Vitreoretinal Center, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California; 2Department of Ophthalmology, Wake Forest University School of Medicine, Winston-Salem, North CarolinaCorrespondence: Darius M Moshfeghi Tel +1 (650) 723-6995Email dariusm@stanford.eduAbstract: Telemedicine has emerged as a potential solution to face the disproportion between infants that need to be screened for retinopathy of prematurity (ROP) and the lack of ophthalmologists. We evaluated its utility in the follow-up after off-label intravitreal injection of bevacizumab. None of the treated infants ended up with bad anatomic outcome. Telemedicine is an alternative safe method to monitor patients after treatment.Keywords: pediatric retina, retina, pediatric ophthalmologyJi MHCallaway NFGreven MAVail DMoshfeghi DMDove Medical Pressarticlepediatric retinaretinapediatric ophthalmologyOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 14, Pp 1161-1163 (2020)
institution DOAJ
collection DOAJ
language EN
topic pediatric retina
retina
pediatric ophthalmology
Ophthalmology
RE1-994
spellingShingle pediatric retina
retina
pediatric ophthalmology
Ophthalmology
RE1-994
Ji MH
Callaway NF
Greven MA
Vail D
Moshfeghi DM
Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
description Marco H Ji,1 Natalia F Callaway,1 Margaret A Greven,2 Daniel Vail,1 Darius M Moshfeghi1 1Byers Eye Institute, Horngren Family Vitreoretinal Center, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California; 2Department of Ophthalmology, Wake Forest University School of Medicine, Winston-Salem, North CarolinaCorrespondence: Darius M Moshfeghi Tel +1 (650) 723-6995Email dariusm@stanford.eduAbstract: Telemedicine has emerged as a potential solution to face the disproportion between infants that need to be screened for retinopathy of prematurity (ROP) and the lack of ophthalmologists. We evaluated its utility in the follow-up after off-label intravitreal injection of bevacizumab. None of the treated infants ended up with bad anatomic outcome. Telemedicine is an alternative safe method to monitor patients after treatment.Keywords: pediatric retina, retina, pediatric ophthalmology
format article
author Ji MH
Callaway NF
Greven MA
Vail D
Moshfeghi DM
author_facet Ji MH
Callaway NF
Greven MA
Vail D
Moshfeghi DM
author_sort Ji MH
title Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
title_short Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
title_full Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
title_fullStr Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
title_full_unstemmed Telemedicine Follow-Up for Intravitreal Bevacizumab Injection in the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) Cohort
title_sort telemedicine follow-up for intravitreal bevacizumab injection in the stanford university network for diagnosis of retinopathy of prematurity (sundrop) cohort
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/c80a5fc3eb0e413aa81e8dab410cd517
work_keys_str_mv AT jimh telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort
AT callawaynf telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort
AT grevenma telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort
AT vaild telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort
AT moshfeghidm telemedicinefollowupforintravitrealbevacizumabinjectioninthestanforduniversitynetworkfordiagnosisofretinopathyofprematuritysundropcohort
_version_ 1718397712375742464